This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Prudential (PRU) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Prudential (PRU) closed at $119.16, marking a +1.9% move from the previous day.
Should Principal Value ETF (PY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PY
Is Principal Value ETF (PY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PY
Berkshire (BRK.B) Ups Insurance Game With $11.6B Alleghany Deal
by Zacks Equity Research
Berkshire Hathaway (BRK.B) agrees to purchase conglomerate Alleghany, ending Warren E. Buffett's six-year drought of large buyouts.
Prudential (PRU) to Buy Minority Stake in Alexander Forbes
by Zacks Equity Research
Prudential (PRU) to expand in Africa with buyout of minority stake in Alexander Forbes in partnership with LeapFrog Investments Group.
Prudential (PRU) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Prudential (PRU) closed at $115.23 in the latest trading session, marking a -0.15% move from the prior day.
Prudential (PRU) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Prudential (PRU) closed at $115.40 in the latest trading session, marking a +1.26% move from the prior day.
Prudential (PRU) Stock Moves -0.09%: What You Should Know
by Zacks Equity Research
Prudential (PRU) closed at $106.05 in the latest trading session, marking a -0.09% move from the prior day.
Prudential (PRU) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Prudential (PRU) closed at $106.15 in the latest trading session, marking a -0.69% move from the prior day.
Prudential Financial (PRU) Up 27.3% in a Year: More Room to Run?
by Zacks Equity Research
Prudential Financial (PRU) stock soars on the back of higher variable investment income, cost savings initiatives and effective capital deployment.
Allstate (ALL) Boosts Shareholder Value With Dividend Hike
by Zacks Equity Research
Allstate's (ALL) recent dividend hike highlights the company's robust financial standing and commitment to sustain its solid capital deployment history.
Insurance ETFs to Rally on Solid Q4 Earnings
by Sweta Killa
Some of the prominent players in the insurance industry surpassed estimates for both earnings and revenues.
Arch Capital (ACGL) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Arch Capital (ACGL) fourth-quarter results reflect a rise in premiums across the company's Insurance and Reinsurance segments, partly offset by lower net investment income.
American Financial (AFG) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
American Financial's (AFG) fourth-quarter results reflect top-line growth stemming from higher net investment income. Better underwriting results in Specialty P&C Group remain noteworthy.
CNA Financial (CNA) Beats on Q4 Earnings, Hikes Dividend
by Zacks Equity Research
CNA Financial's (CNA) fourth-quarter results indicate sound P&C business operations and lowest combined ratio achieved in the last five years, partly offset by higher claims, benefits and expenses.
RenaissanceRe (RNR) Okays Dividend Hike, Boosts Shareholder Value
by Zacks Equity Research
RenaissanceRe's (RNR) latest dividend hike is reflective of its sound financial position and sincere efforts to reward shareholders.
Prudential Financial (PRU) Beats on Q4 Earnings, Hikes Dividend
by Zacks Equity Research
Prudential Financial's (PRU) fourth-quarter results benefit on the back of robust performances of U.S. Businesses and International Businesses, partly offset by a fall in overall revenues.
Prudential (PRU) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of 33.05% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
This 1 Finance Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Will Lower Net Investment Income Hurt MetLife (MET) Q4 Earnings?
by Zacks Equity Research
MetLife's (MET) fourth-quarter results are likely to reflect volume growth and sound contribution from the Latin America segment.
Will Prudential (PRU) Retain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q4 results are likely to reflect strong investment performance, higher earnings from joint venture investments and higher variable life sales.
Prudential (PRU) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Prudential (PRU) closed at $110.19 in the latest trading session, marking a -0.38% move from the prior day.
Prudential (PRU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Prudential (PRU) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why the Earnings Surprise Streak Could Continue for Prudential (PRU)
by Zacks Equity Research
Prudential (PRU) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Top Analyst Reports for AbbVie, Edwards Lifesciences & Johnson Controls
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Edwards Lifesciences Corporation (EW), and Johnson Controls International plc (JCI).